AHA Urges HHS to Stop Drug Companies’ Refusal to Provide Required 340b Discounts

AHA follows up on our previous correspondence on the serious situation Eli Lilly, AstraZeneca and Sanofi are creating for the nation’s most vulnerable communities by refusing to comply with the requirements of the 340B program to sell to contract pharmacies at the discounts required by section 340B of the Public Health Service Act.